SMC is a 40 year old firm with unique breadth across corporate advisory, licensing and strategic partnerships, investment banking and policy.

Corp Advisory: Advise industry leaders across innovators & biosimilars, generics on global growth and strategy, external research and partnerships.

Innovation: Our transaction experience spans novel drugs, 505(b)(2) and vaccines. We represent large companies on both sell-side & buy-side/scouts, pioneering young ventures and several marque institutions where we manage all licensing and tech transfer.

Ops and ESG: We champion biotransformation and operations decarbonization with sector focused expertise

Global health: We work with global health actors & industry to steer sustainable access to affordable and quality assured health products, and have shaped strategic interventions for regional manufacturing and health system resilience

Sathguru Catalyzers is SMC's affiliate VC fund that invests in innovation led life science ventures